Regeneron Pharmaceuticals (REGN) Income Tax Expense & History | Stock Alarm

Demo Sign up Log In

Regeneron Pharmaceuticals · Income Tax Expense

REGN Income Tax Expense

Latest reported$837.30Mperiod endingJun 30, 2026

REGN Income Tax ($0.00 → $837.30M)

Annual income tax expense

High-resolution chart · PNG

REGN income tax expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Income Tax Expense — Annual fiscal periods (USD)
Period ending	Income Tax Expense (USD)
Dec 31, 2025	725,800,000
Dec 31, 2024	367,300,000
Dec 31, 2023	245,700,000
Dec 31, 2022	520,400,000
Dec 31, 2021	1,250,500,000
Dec 31, 2020	297,200,000
Dec 31, 2019	313,300,000
Dec 31, 2018	109,100,000
Dec 31, 2017	880,000,000
Dec 31, 2016	434,293,000
Dec 31, 2015	589,041,000
Dec 31, 2014	427,673,000
Dec 31, 2013	288,998,000
Dec 31, 2012	-335,848,000
Dec 31, 2011	-1,132,000
Dec 31, 2010	0
Dec 31, 2009	-4,122,000
Dec 31, 2008	2,351,000
Dec 31, 2007	-29,751,000
Dec 31, 2006	-21,866,000
Dec 31, 2005	178,846,000
Dec 31, 2004	-84,281,000
Dec 31, 2003	3,008,000
Dec 31, 2002	-7,011,000
Dec 31, 2001	-21,663,000
Dec 31, 2000	2,514,000
Dec 31, 1999	-1,700,000
Dec 31, 1998	-8,400,000
Dec 31, 1997	7,500,000
Dec 31, 1996	29,400,000
Dec 31, 1995	30,600,000
Dec 31, 1994	1,500,000
Dec 31, 1993	1,100,000
Dec 31, 1992	800,000
Dec 31, 1991	-10,300,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.